<DOC>
<DOCNO>
EP-0000727
</DOCNO>
<TEXT>
<DATE>
19790221
</DATE>
<IPC-CLASSIFICATIONS>
<main>C07D-417/10</main> C07D-275/00 A61K-31/505 A61K-31/425 C07D-275/04 
</IPC-CLASSIFICATIONS>
<TITLE>
3-(4-(1,3-diazacycloalkene-2-yl)-phenyl)-1,2-benzisothiazoles, process for their preparation and medicaments containing them.
</TITLE>
<APPLICANT>
basf agde <sep>basf aktiengesellschaft<sep>basf aktiengesellschaft carl-bosch-strasse 38 67063 ludwigshafen de<sep>basf aktiengesellschaft<sep>
</APPLICANT>
<INVENTOR>
hagen helmut dr<sep>lenke dieter dr<sep>von philipsborn gerda dr<sep>hagen, helmut, dr.<sep>lenke, dieter, dr<sep>von philipsborn, gerda, dr.<sep>hagen, helmut, dr.max-slevogt-strasse 17ed-6710 frankenthalde<sep>lenke, dieter, drkekuleplatz 1d-6700 ludwigshafende<sep>von philipsborn, gerda, dr.naechstenbacher weg 35d-6940 weinheimde<sep>hagen, helmut, dr.<sep>lenke, dieter, dr <sep>von philipsborn, gerda, dr.  <sep>hagen, helmut, dr.max-slevogt-strasse 17ed-6710 frankenthalde<sep>lenke, dieter, drkekuleplatz 1d-6700 ludwigshafende<sep>von philipsborn, gerda, dr.naechstenbacher weg 35d-6940 weinheimde<sep>
</INVENTOR>
<ABSTRACT>
Compounds of formula I in the R is a hydrogen atom, an alkyl radical having 1 to 4 C atoms, an alkoxy group having 1 to 3 C atoms, a halogen atom or a nitro group, and Y represents a bridge member of the formula and whose acid addition salts whoseProduction and pharmaceutical preparations with these compounds as active ingredients that can be used for pharmacotherapy of cardiac arrhythmias.
</ABSTRACT>
</TEXT>
</DOC>
